Direct-acting anti-viral (DAAs) therapies have changed the hepatitis C landscape.Rather than ‘can we cure?’, the question is now ‘who should we cure first?’ Continue reading →
Enter your email address to subscribe to this blog and receive notifications of new posts by email.
Join 4,457 other followers
INPUD on FaceBook
Unit 2C05, South Bank Technopark
90 London Road, London
SE1 6LN, United Kingdom
+44 (0) 20 7112 8781